Study of activities of the succinate dehydrogenase-coenzyme Q reductase in leucocytes of patients with controlled hypertension.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000201:enzymology*; D007962:Leukocytes / Q000201:enzymology*; D008297:Male; D008875:Middle Aged; D009247:NADH, NADPH Oxidoreductases / Q000097:blood*; D011808:Quinone Reductases / Q000097:blood*; D012964:Sodium / Q000378:metabolism; D013385:Succinate Dehydrogenase / Q000097:blood*; D014451:Ubiquinone / Q000097:blood*
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D014451:Ubiquinone; D012964:Sodium; D013385:Succinate Dehydrogenase; D009247:NADH, NADPH Oxidoreductases; D011808:Quinone Reductases